Biocorp : 2021 financial calendar

Communiqué de Presse

BIOCORP: 2021 financial calendar

Issoire, France, January 6th, 2021, 06h00 pm CET - BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, updates its financial reporting schedule for

2020*:

	Annonce		Date*
	2020 full-year results		Thursday, April 8th, 2021
			Before the market opening
	Annual shareholders meeting		Friday, May 7th, 2021
	2020 first-half results		Thursday, September 23rd, 2021
		Before the market opening

• This schedule is indicative and subject to change.

À PROPOS DE BIOCORP

Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics. Available for sale since late 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 63 employees.

BIOCORP is listed on Alternext since July 2015 (FR0012788065 - ALCOR). For more information, please visit www.biocorpsys.com

Follow us on Twitter @BIOCORPSystems

BIOCORP CONTACTS
Jacques Gardette	Éric Dessertenne	Sylvaine Dessard
Chairman of the Board	CEO	Marketing @ Communication Director
[e-mail]		[e-mail]
		+ 33 (0)6 88 69 72 85

ULYSSE COMMUNICATION CONTACTS
Bruno ARABIAN	Nicolas DANIELS
[e-mail]	[e-mail]
[phone]	[phone]